MODERNA

World Rank (Jan-07-2022)
188
Market Value (Jan-07-2022)
86.710 Billion USD
World Rank (Sep-01-2021)
87
Market Cap (Sep-01-2021)
152.050 Billion USD
World Rank (Jan-01-2021)
413
Market Value (Jan-01-2021)
41.340 Billion USD
World Rank (Jan-2020)
2,187
Market Value (Jan 1st 2020)
6.581 Billion USD
Annual Revenue in USD
803.000 Million USD
Annual Results for Year Ending
Dec-2020
Annual Net Income in USD
-747.000 Million USD
Stock Category
S&P 500
Headquarters Country
USA
World Sub Region
Northern America
Rank in Country (Jan-2020)
Rank in USA in 2020 is 737
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 185
IPO Year
2018
Company Business
Healthcare
Biotechnology
Biopharmaceutical
Number of Employees
1,800
Employee Count as on Date
As on 2021
Founded Year
2010
Stock Exchange
Frankfurt
Nasdaq
Yahoo @ Nasdaq
Wikipedia
Company Website:
MODERNA
Business Sector:
Top Healthcare Companies in USA
Top Bio Pharmaceutical Companies in USA
Annual Revenue
803.4 Million USD for Year ending December-2020
Annual Operating Income
-763.1 Million USD (Operating Loss) for Year ending December-2020
Annual Net Income
-747 Million USD (Net Loss) Million USD for Year ending December-2020
Total Assets
4,651 Million USD as on September 2020
Total Liabilities
1,891 Million USD as on September 2020
Total Equity
2,759 Million USD as on September 2020
About Company Business:

Moderna is Biotechnology sector company with headquarters in Massachusetts, USA. It is working actively to find Covid-19 vaccine.

Annual Results Summary:

Moderna - Annual Results - in Million USD

Year Ending Total Revenue Gross Profit Operating Income Net Income
Dec-2020 803.4 795.4 (763.1) (Loss) (747.0) (Loss)
Dec-2019 60.2 60.2 (545.7) (Loss) (514.0) (Loss)
Dec-2018 135.1 135.1 (413.3) (Loss) (384.7) (Loss)
Dec-2017 205.8 205.8 (269.4) (Loss) (255.9) (Loss)
Dec-2016 108.4 108.4 (223.8) (Loss) (216.2) (Loss)
Balance Sheet Summary

Moderna - Balance Sheet Summary - in Million USD

Year Ending:

 Total Assets Total Current Liabilities Total Liabilities Total Equity
Dec-2020 7,337 4,389 4,775 2,561
Dec-2019 1,589 143 415 1,175
Dec-2018 1,962 223 432 1,530
Dec-2017 1,084 191 459 -551
Quarterly Results Summary:

Moderna - Quarterly Results Summary - in Million USD

Quarterly Ending: Total Revenue Gross Profit Operating Income Net Income
Sep-2021 4,969 4,247 3,558 3,333
Jun-2021 4,354 3,604 3,062 2,780
Mar-2021 1,937 1,744 1,266 1,221
Dec-2020 570.7 562.8 -275 (Loss) -272 (Loss)
Sep-2020 157.9 157.9 (235.1) (Loss) (233.6) (Loss)
Jun-2020 66.4 66.4 (122.1) (Loss) (116.7) (Loss)
Mar-2020 8.4 8.4 (130.9) (Loss) (124.2) (Loss)
Dec-2019 14.1 14.1 (129.6) (Loss) (123.3) (Loss)

Share it on Social Media